Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer by Helen Y. Hougen, Ryon P. Graf, Gerald Li, Julia C.F. Quintanilha, Douglas I. Lin, Jeffrey S. Ross, Sanoj Punnen, Brandon A. Mahal

Get full text

<i>MKX-AS1</i> Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients by Ricardo D. Gonzalez, George W. Small, Adrian J. Green, Farida S. Akhtari, Alison A. Motsinger-Reif, Julia C. F. Quintanilha, Tammy M. Havener, David M. Reif, Howard L. McLeod, Tim Wiltshire

Get full text

<i>RYK</i> Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients by Ricardo D. Gonzalez, George W. Small, Adrian J. Green, Farida S. Akhtari, Tammy M. Havener, Julia C. F. Quintanilha, Amber B. Cipriani, David M. Reif, Howard L. McLeod, Alison A. Motsinger-Reif, Tim Wiltshire

Get full text

MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer by Julia C. F. Quintanilha, Maria A. Cursino, Jessica B. Borges, Nadine G. Torso, Larissa B. Bastos, Juliana M. Oliveira, Thiago S. Cobaxo, Eder C. Pincinato, Mario H. Hirata, Murilo V. Geraldo, Carmen S. P. Lima, Patricia Moriel

Get full text

Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance) by Julia C.F. Quintanilha, Alexander B. Sibley, Yingmiao Liu, Donna Niedzwiecki, Susan Halabi, Layne Rogers, Bert O’Neil, Hedy Kindler, William Kelly, Alan Venook, Howard L. McLeod, Mark J. Ratain, Andrew B. Nixon, Federico Innocenti, Kouros Owzar

Get full text

Can acetylcysteine ameliorate cisplatin‐induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double‐blind, placebo‐controlled trial involvin... by Marília B. Visacri, Júlia C. F. Quintanilha, Vanessa M. deSousa, Laís S. Amaral, Rosiane de F. L.Ambrósio, Luciane Calonga, Silvia F. B. B. Curi, Mayra F. de T.Leme, Carlos T. Chone, João M. C. Altemani, Priscila G. Mazzola, Carina Malaguti, Aníbal E. Vercesi, Carmen S. P. Lima, Patricia Moriel

Get full text

Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab by Douglas I. Lin, Julia C. F. Quintanilha, Natalie Danziger, Lixin Lang, Diane Levitan, Cynthia Hayne, Matthew C. Hiemenz, David L. Smith, Lee A. Albacker, Jeffrey Leibowitz, Douglas A. Mata, Brennan Decker, Sotirios Lakis, Nimesh R. Patel, Ryon P. Graf, Julia A. Elvin, Jeffrey S. Ross, Varun Pattani, Richard S. P. Huang, Amy K. Wehn

Get full text

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types by Vivek Subbiah, Samuel J Klempner, Neeraj Agarwal, David P Carbone, Amit Mahipal, Shilpa Gupta, David Fabrizio, Jeffrey S Ross, Gerald Li, David R Gandara, Miles C Andrews, Jonathan W Riess, Ramez N Eskander, Ryon P Graf, Geoffrey R Oxnard, Sarah Sammons, Jeremy Snider, Lilia Bouzit, Cheryl Cho-Phan, Megan Price, Julia C F Quintanilha, Richard Sheng Poe Huang

Get full text